Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Gastroenterology
|
February 28, 2018
Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times
Somak Roy, William A LaFramboise, Ta-Chiang Liu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 8, 2020
KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy
Laura A Favazza, Christine M Parseghian, Cihan Kaya, et al.
Blood Advances
|
May 26, 2023
Current clinical practices and challenges in molecular testing: a GOAL Consortium Hematopathology Working Group report
Thomas D Lee, Dara L Aisner, Marjorie P David, et al.
Blood Advances
|
May 2, 2025
NTRK1-rearranged histiocytosis: clinicopathologic and molecular features
Rivers Fragneau, Sylvie Fraitag, Paul G Kemps, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 5, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)
Peter Horak, Malachi Griffith, Arpad M Danos, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
February 1, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)
Peter Horak, Malachi Griffith, Arpad M Danos, et al.
Nature Medicine
|
March 26, 2025
Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumors
Areeba Patel, Kirsten Göbel, Sebastian Ille, et al.
Blood
|
November 2, 2021
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
Paul G Kemps, Jennifer Picarsic, Benjamin H Durham, et al.
The New England Journal of Medicine
|
November 5, 2015
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
, W Marston Linehan, Paul T Spellman, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Gastroenterology
|
February 28, 2018
Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times
Somak Roy, William A LaFramboise, Ta-Chiang Liu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 8, 2020
KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy
Laura A Favazza, Christine M Parseghian, Cihan Kaya, et al.
Blood Advances
|
May 26, 2023
Current clinical practices and challenges in molecular testing: a GOAL Consortium Hematopathology Working Group report
Thomas D Lee, Dara L Aisner, Marjorie P David, et al.
Blood Advances
|
May 2, 2025
NTRK1-rearranged histiocytosis: clinicopathologic and molecular features
Rivers Fragneau, Sylvie Fraitag, Paul G Kemps, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 5, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)
Peter Horak, Malachi Griffith, Arpad M Danos, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
February 1, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)
Peter Horak, Malachi Griffith, Arpad M Danos, et al.
Nature Medicine
|
March 26, 2025
Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumors
Areeba Patel, Kirsten Göbel, Sebastian Ille, et al.
Blood
|
November 2, 2021
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
Paul G Kemps, Jennifer Picarsic, Benjamin H Durham, et al.
The New England Journal of Medicine
|
November 5, 2015
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
, W Marston Linehan, Paul T Spellman, et al.
Page
of 8